These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 520728

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R.
    Clin Ter; 1979 Mar 15; 88(5):461-12. PubMed ID: 466968
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G, Scali G, Casa B, Nonis E.
    Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445
    [No Abstract] [Full Text] [Related]

  • 4. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
    Cacciatori D.
    Clin Ter; 1979 Jun 15; 89(5):473-82. PubMed ID: 535324
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Experience with the use of cavinton in the treatment of patients with incipient senile atherosclerotic encephalopathy].
    Man'kovskiĭ NB, Mints AIa, Karaban' IN, Litvinenko AA, Bachinskaia NIu.
    Vrach Delo; 1987 Jan 15; (1):46-9. PubMed ID: 3564418
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of kavinton on the hemodynamics and adenosine metabolism in atherosclerosis patients].
    Mikunis RI, Serkova VK, Zhebel' VN.
    Vrach Delo; 1988 Jul 15; (7):27-9. PubMed ID: 3188457
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E, Di Lorenzo L, De Pergola G.
    G Clin Med; 1980 Aug 15; 61(8):628-42. PubMed ID: 7004986
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P, Periti G, Colombo Pirola L.
    Clin Ter; 1981 Apr 30; 97(2):137-45. PubMed ID: 7016415
    [No Abstract] [Full Text] [Related]

  • 18. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM, Shprakh VV, Savkov VS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Apr 30; 88(1):39-44. PubMed ID: 3364094
    [Abstract] [Full Text] [Related]

  • 19. The effect of Cavinton on cerebrovascular resistance and its use in ophthalmological patients. A double-blind trial.
    Imre G, Németh B.
    Ther Hung; 1981 Apr 30; 29(3):120-3. PubMed ID: 7188137
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P, Crocq L, Bernard JG.
    Sem Hop; 1969 Jan 26; 45(5):312-7. PubMed ID: 4307724
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.